Press Release: Autolus : Autolus Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
LONDON, April 02, 2025 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing,
Read full article »
Autolus is a biopharmaceutical company that develops and commercializes T-cell immunotherapies for the treatment of cancer.
Read more